Immunomodulatory Agents for Coronavirus Disease-2019 Pneumonia

Morbidity and mortality from COVID-19 is due to severe inflammation and end-organ damage caused by a hyperinflammatory response. Multiple immunomodulatory agents to attenuate this response have been studied. Corticosteroids, specifically dexamethasone, have been shown to reduce mortality in hospital...

Descripción completa

Detalles Bibliográficos
Autores principales: McManus, Dayna, Davis, Matthew W., Ortiz, Alex, Britto-Leon, Clemente, Dela Cruz, Charles S., Topal, Jeffrey E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678826/
https://www.ncbi.nlm.nih.gov/pubmed/37085221
http://dx.doi.org/10.1016/j.ccm.2022.11.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678826/
https://www.ncbi.nlm.nih.gov/pubmed/37085221
http://dx.doi.org/10.1016/j.ccm.2022.11.009

Ejemplares similares